Literature DB >> 9254668

Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1.

M Criado1, E Domínguez del Toro, C Carrasco-Serrano, F I Smillie, J M Juíz, S Viniegra, J J Ballesta.   

Abstract

Adrenomedullary chromaffin cells express at least two subtypes of acetylcholine nicotinic receptors, which differ in their sensitivity to the snake toxin alpha-bungarotoxin. One subtype is involved in the activation step of the catecholamine secretion process and is not blocked by the toxin. The other is alpha-bungarotoxin-sensitive, and its functional role has not yet been defined. The alpha7 subunit is a component of this subtype. Autoradiography of bovine adrenal gland slices with alpha-bungarotoxin indicates that these receptors are restricted to medullary areas adjacent to the adrenal cortex and colocalize with the enzyme phenylethanolamine N-methyl transferase (PNMT), which confers the adrenergic phenotype to chromaffin cells. Transcripts corresponding to the alpha7 subunit also are localized exclusively to adrenergic cells. To identify possible transcriptional regulatory elements of the alpha7 subunit gene involved in the restricted expression of nicotinic receptors, we isolated and characterized its 5' flanking region, revealing putative binding sites for the immediate early gene transcription factor Egr-1, which is known to activate PNMT expression. In reporter gene transfection experiments, Egr-1 increased alpha7 promoter activity by up to sevenfold. Activation was abolished when the most promoter-proximal of the Egr-1 sites was mutated, whereas modification of a close upstream site produced a partial decrease of the Egr-1 response. Because Egr-1 was found to be expressed exclusively in adrenergic cells, we suggest that this transcription factor may be part of a common mechanism involved in the induction of the adrenergic phenotype and the differential expression of alpha-bungarotoxin-sensitive nicotinic receptors in the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254668      PMCID: PMC6573139     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals.

Authors:  X M Cao; R A Koski; A Gashler; M McKiernan; C F Morris; R Gaffney; R V Hay; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

Review 2.  The diversity of neuronal nicotinic acetylcholine receptors.

Authors:  P B Sargent
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

3.  Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits.

Authors:  A Campos-Caro; F I Smillie; E Domínguez del Toro; J C Rovira; F Vicente-Agulló; J Chapuli; J M Juíz; S Sala; F Sala; J J Ballesta; M Criado
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

4.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 5.  Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons.

Authors:  D S McGehee; L W Role
Journal:  Annu Rev Physiol       Date:  1995       Impact factor: 19.318

6.  Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation.

Authors:  A J Cole; D W Saffen; J M Baraban; P F Worley
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

7.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Authors:  K L Guan; J E Dixon
Journal:  Anal Biochem       Date:  1991-02-01       Impact factor: 3.365

8.  Characterization of Nicotinic Acetylcholine Receptors Expressed by Cells of the SH-SY5Y Human Neuroblastoma Clonal Line.

Authors:  R J Lukas; S A Norman; L Lucero
Journal:  Mol Cell Neurosci       Date:  1993-02       Impact factor: 4.314

9.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.

Authors:  D S McGehee; M J Heath; S Gelber; P Devay; L W Role
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

10.  alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha 7 subunit.

Authors:  M García-Guzmán; F Sala; S Sala; A Campos-Caro; W Stühmer; L M Gutiérrez; M Criado
Journal:  Eur J Neurosci       Date:  1995-04-01       Impact factor: 3.386

View more
  19 in total

1.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

2.  Nicotine stimulates expression of the PNMT gene through a novel promoter sequence.

Authors:  Marian J Evinger; Elizabeth Mathew; Stefan Cikos; James F Powers; Ying-Shuan E Lee; Sabina Sheikh; Robert A Ross; Arthur S Tischler
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.

Authors:  C J Herrero; E García-Palomero; A J Pintado; A G García; C Montiel
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Expression of a neuronal nicotinic acetylcholine receptor in insect and mammalian host cell systems.

Authors:  E M Aztiria; M C Sogayar; F J Barrantes
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

5.  Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7.

Authors:  Andrew Canastar; Judith Logel; Sharon Graw; Jessica Finlay-Schultz; Christina Osborne; Milda Palionyte; Carla Drebing; Molly Plehaty; Lisa Wilson; Rosemary Eyeson; Sherry Leonard
Journal:  J Mol Neurosci       Date:  2011-11-04       Impact factor: 3.444

Review 6.  Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.

Authors:  Arik J Hone; J Michael McIntosh
Journal:  FEBS Lett       Date:  2017-10-27       Impact factor: 4.124

Review 7.  Human nicotinic receptors in chromaffin cells: characterization and pharmacology.

Authors:  Almudena Albillos; J Michael McIntosh
Journal:  Pflugers Arch       Date:  2017-10-20       Impact factor: 3.657

8.  Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.

Authors:  M G López; C Montiel; C J Herrero; E García-Palomero; I Mayorgas; J M Hernández-Guijo; M Villarroya; R Olivares; L Gandía; J M McIntosh; B M Olivera; A G García
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.

Authors:  Arik J Hone; J Michael McIntosh; Layla Azam; Jon Lindstrom; Linda Lucero; Paul Whiteaker; Juan Passas; Jesús Blázquez; Almudena Albillos
Journal:  Mol Pharmacol       Date:  2015-09-01       Impact factor: 4.436

10.  An egr-1 (zif268) antisense oligodeoxynucleotide infused into the amygdala disrupts fear conditioning.

Authors:  Seema Malkani; Karin J Wallace; Melanie P Donley; Jeffrey B Rosen
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.